U U.S. News Guest Jul 29, 2025 #1 The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August. Continue reading...
The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August. Continue reading...